BSAC collaborates on Global Forum on Sustainable Access to Effective Antibiotics

BSAC will today, 20 September 2016, collaborate on the delivery of the Forum on Sustainable Access to Effective Antibiotics to be held 1600-1830hours at The Yale Club of New York City

The event has been organised by the CDDEP Global Antibiotic Resistance Partnership, in collaboration with The British Society for Antimicrobial Chemotherapy, The German Center for Infection Research, The Infectious Diseases Society of America, The Norwegian Institute of Public Health, The Pew Charitable Trusts, and The Wellcome Trust, and is being held ahead of the United Nations General Assembly (UNGA) on 21 September which will confront the global threat of AMR. 

It is only the fourth time a health topic has been discussed at a high-level UNGA meeting and the session provides a powerful opportunity to organize the global response to AMR and ensure that they have many locations for the future sustainability of antibiotics.

Global leaders in the field of AMR — including presidents, UN agency directors, and industry CEOs — will discuss the issue o AMR at the forum, and three solar panels will address the pillars of AMR control: stewardship and conservation, innovation, and global accountability and governance. The BSAC President, Professor Dilip Nathwani, OBE, will respond to the panel discussion on Stewardship and Conservation.



Please participate by sharing, tweeting ahead of and during the live event, and following the BSAC website to see/share/tweet our press release (at 2000hrs this evening) and response to the UNGA meeting on 21 September.


The British Society for Antimicrobial Chemotherapy (BSAC) is an inter-professional organization with over 40 years of experience and achievement in antibiotic education, research and leadership and is dedicated to saving lives through appropriate use and development of antibiotics now and in the future. BSAC publishes the Journal of Antimicrobial Chemotherapy, the leading international journal in its field, and leads Antibiotic Action, a UK led global initiative that seeks to ensure effective antibiotics are researched, discovered and developed for all who need them. The Society engages with a wide range of stakeholders to improve and promote understanding of antimicrobials, including peer organizations, parliamentarians, policy-makers, students and healthcare trainees, scientists, researchers and journalists.


German Center for Infection Research

At the German Center for Infection Research (DZIF), about 500 researchers from 35 institutions throughout Germany jointly develop new approaches for the prevention, diagnosis and treatment of infectious diseases. The aim of this nationwide collaboration between universities, hospitals and research institutions is to translate research results into clinical practice quickly and effectively. With this, the DZIF paves the way for developing new vaccines, diagnostic agents and drugs to treat infections. The DZIF is one of six German Centers for Health Research established by the Federal Ministry of Education and Research to combat the most common diseases. More information can be found at

Global Antibiotic Resistance Partnership (GARP)

The aim of the Global Antibiotic Resistance Partnership (GARP) is to empower countries to tackle the issue of antibiotic resistance by establishing local, in-country policy analysis and policy development capacity related to antibiotic resistance. GARP began in 2009 in India, Kenya, South Africa, and Vietnam, expanding to Mozambique, Nepal, Tanzania, and Uganda in 2012 and to Bangladesh, Cambodia, Laos, Pakistan, Zambia, and Zimbabwe in 2016.

Infectious Diseases Society of America

The Infectious Diseases Society of America represents more than 10,000 infectious diseases physicians and scientists devoted to patient care, prevention, public health, education, and research in the area of infectious diseases. IDSA members share a passion for protecting and improving the health of individuals and communities at home and around the globe. IDSA members highlight and illustrate the value of ID physicians, and the critical roles they play in protecting and promoting public health, and driving biomedical research and innovation ensuring patients receive safe and effective care.

The Norwegian Institute of Public Health (NIPH) is a governmental institution placed under the Ministry of Health and Care Services.

We are an official national institution that serves as the technical reference source on public health matters for governmental authorities, the general public, health services, researchers, the judiciary, prosecuting authorities, political bodies and the media.

NIPH has been actively involved in international work and academic research linked to policies to combat AMR. We have led the work on a series of papers in The Lancet on access and sustainable effectiveness of antimicrobials, and have been used as external experts to work at WHO on development of the Global Action Plan and the development and stewardship framework. In addition we are academic leads on the work package on new business models within the Innovative Medicines Initiative (IMI) funded DRIVE AB project which is the joint European project on how we could boost innovation for new antimicrobials.

The Pew Charitable Trusts

The Pew Charitable Trusts is driven by the power of knowledge to solve today’s most challenging problems. Pew applies a rigorous, analytical approach to improve public policy, inform the public and invigorate civic life.

Wellcome exists to improve health for everyone by helping great ideas to thrive. We’re a global charitable foundation, both politically and financially independent. We support scientists and researchers, take on big problems, fuel imaginations and spark debate.